MAGN director reports 9,501 RSUs settled; 21,533 direct holding
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Magnera Corp (MAGN) director Bruce Brown reported an equity award settlement. On 11/04/2025, 9,501 shares of common stock were acquired via transaction code M, reflecting the conversion of restricted stock units. The Form 4 shows a share price entry of $8.53 on the non-derivative line.
Following the transaction, Brown beneficially owns 21,533 shares directly and 17,228 shares indirectly through the Bruce Brown Revocable Trust. The derivative table lists 9,501 RSUs converted into common stock at a derivative price of $0, with 0 RSUs remaining afterward. A footnote states the FY2025 Director grant vests in full and all restrictions lapse one year from the grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary
9,501 shares exercised/converted
Mixed
3 txns
Insider
Brown Bruce
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 9,501 | $0.00 | -- |
| Exercise | Common Stock, Par Value $.01 | 9,501 | $8.53 | $81K |
| holding | Common Stock, Par Value $.01 | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 0 shares (Direct);
Common Stock, Par Value $.01 — 21,533 shares (Direct);
Common Stock, Par Value $.01 — 17,228 shares (Indirect, Bruce Brown Revocable Trust)
Footnotes (1)
- Not applicable to this transaction. RSUs have no value until all restrictions lapse on the final vesting date. This FY2025 Director grant vests in full and all restrictions lapse one year from the Grant Date.
FAQ
What did Magnera (MAGN) director Bruce Brown report on Form 4?
Acquisition of 9,501 shares of common stock on 11/04/2025 via code M, reflecting RSU conversion.
What derivative securities were involved in the MAGN Form 4?
The filing shows 9,501 restricted stock units converted into common stock at a derivative price of $0, leaving 0 RSUs afterward.
What price appears for the MAGN non-derivative acquisition?
The non-derivative line lists a price of $8.53 for the 9,501 shares acquired.
What does the footnote say about the FY2025 Director RSU grant?
It states the grant vests in full and all restrictions lapse one year from the Grant Date.